News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer
Kristina Jankovic/X
Jan 20, 2025, 13:56

Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer

Kristina Jankovic, Medical Oncology Resident at University Clinical Center Nis, shared a post on X:

“DC Approval!! US FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- Breast Cancer previously treated with endocrine and chemotherapy for unresectable, metastatic disease. ”

Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer

Additional Information

cancer Kristina Jankovic OncoDaily Oncology
Special Coverage
Insight
Aug 18, 2025, 13:32
Andrew Peterson: Is it Time We Stop Routinely Removing the Non-Diseased Tonsil?
Voices
Aug 18, 2025, 13:30
Over 700 Voices, One Message: A Cancer Workforce Action Plan Is Urgent - ECO
Voices
Aug 18, 2025, 13:06
Anirban Maitra Highlights a Decade of Pancreatic Cancer Research Memories
Insight
Aug 18, 2025, 13:03
Tom Powles Shared Positive Results from IMVIGOR011 Bladder Cancer Trial
Voices
Aug 18, 2025, 13:01
June Khaw: NSW Cancer Summit 2025 - Breaking Silos, Building Equity in Cancer Care
Science
Aug 18, 2025, 12:53
Breast Cancer Study Shows Reversal of Estrogen Receptor Gene Programs
Voices
Aug 18, 2025, 12:52
From France to Rwanda for Palliative Care - ACREOL Global
Voices
Aug 18, 2025, 12:44
Norman Ng: Prevention is Better Than Cure
Blog Posts
Aug 18, 2025, 12:09
Florez Lab Supports Michelle Sanchez in Jimmy Fund Walk for Lung Cancer
Insight
Aug 18, 2025, 11:58
Clinical Mondays: AI-Powered OSCE Training
Science
Aug 18, 2025, 11:52
Estela Rodriguez on CNS Activity of Tarlatamab in Small Cell Lung Cancer
Insight
Aug 18, 2025, 11:35
Oscar Tahuahua: First Prospective Study on Testicular Function After Immune-Checkpoint Inhibitors Treatment